According to the report, the Middle East & Africa Blood Testing Market size is valued at USD 4.57 billion in 2022. It is estimated to be growing at a CAGR of 2.69% to reach USD 5.22 billion by 2027.
Blood testing is a laboratory-based examination performed directly to conclude the general state of health, the occurrence of a bacteria or virus, and to consider disease progression. It is usually performed by taking a small sample of blood from the patient’s body with the help of a needle or finger prick.
A shift in healthcare providers' focus from treatment towards early exposure of diseases, particularly in fields of cardiovascular and endocrinology medicine, has poised the industry to observe lucrative growth during the forecast period. Other notable drivers include introducing various innovative solutions that enable faster and accurate diagnosis by using plasma or serum screening methods. Restraints for the market include the high cost of advanced blood culture techniques and the lack of appropriate reimbursement policies.
This research report on the Middle East & Africa Blood Testing Market has been segmented and sub-segmented into the following categories
Based on region, Africa is leading the blood testing market, and Middle-East is estimated to grow at the highest CAGR in the forecast period.
In the forecast period, the Middle East is expected with the highest market growth, whereas Africa is already a leading market in Blood testing and screening. On big boom to market growth in this region, the government promotes healthcare and facilities within the limited funds. The aim is to provide excellent hospitality and health, reduce stays in the hospitals, and reduce expenses; the government encourages home treatments. Hence the portable blood testing kits then increased market size on a considerable scale.
Disease-related hospitality expenses and health care are also monitored by various government and non-government organizations in Soviet Central Asia. Blood tests can be carried out most outside clinics, Diagnostic centers, physician’s offices, and more growth and ease for the blood testing market. Alongside blood banking units, blood donation camps, and cancer diagnostics are reported at a high rate in South Africa and Nigeria. The other important factor in the Middle East and African upgrading regions are that the focus shift on the point of care diagnostics. Diagnostic offers rapid diagnosis and results for blood tests such as sugar tests, lipid tests, blood glucose and electrolyte, and coagulation tests.
Key Market Companies leading the Middle East & Africa Blood Testing Market Profiled in the Report are Bio-Rad Laboratories Inc. (U.S.), Siemens Healthcare (Germany), Grifols (Spain), Nanosphere Inc. (U.S.), BioMérieux (France), Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Beckman Coulter (U.S.).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 Complete Blood Count
5.1.1.1 Red Blood Cells
5.1.1.2 White Blood Cells
5.1.1.3 Haemoglobin
5.1.1.4 Hematocrit
5.1.1.5 Platelets
5.1.2 Blood Chemistry Tests
5.1.2.1 Test for Electrolytes
5.1.2.2 Blood Glucose
5.1.2.3 Calcium
5.1.2.4 Test for Kidney Function
5.1.3 Blood Enzyme Tests
5.1.3.1 Troponin
5.1.3.2 Creatine Kinase
5.1.4 Blood Clotting Tests
5.1.4.1 Prothrombin time
5.1.4.2 Activated Partial Thromboplastin time
5.1.4.3 Blood Coagulation
5.2 By Diseases
5.2.1 Anaemia
5.2.2 Infection
5.2.3 Leukaemia
5.2.4 Hypokalemia
5.2.5 Kidney Disorders
5.2.6 Heart Attack
5.2.7 Coronary Heart Disease
5.3 By Methods
5.3.1 Manual Blood Culture Testing
5.3.2 Automated Blood Culture Testing
5.3.2.1 Automated Blood Culture System
5.3.2.2 Blood Culture Instruments
6. Geographical Analysis
6.1 Introduction
6.2 Middle-East
6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Bio-Rad Laboratories Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Siemens Healthcare
8.3 Grifols
8.4 Nanosphere Inc.
8.5 BioMérieux
8.6 Dickinson and Company
8.7 Ortho Clinical Diagnostics Inc.
8.8 Roche Diagnostics
8.9 Alere Inc.
8.10 Bruker Corporation
8.11 Abbott Laboratories
8.12 Thermo Fisher Scientific Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
